ANTI-LEPROTIC DRUGS. LEPROSY. INTRODUCTION. Leprosy is a chronic infectious disease caused by Mycobacterium leprae. OR. Leprosy .
drugs for the treatment of leprosy. Under WHO initiative, leprosy treatment is available for all patients, worldwide, free of charge, with drugs donated by
Leprosy is curable with a combination of drugs known as multidrug therapy (MDT), as the treatment of leprosy with only one anti-leprosy drug (monotherapy) will result in development of drug resistance to that drug. Access to treatment. MDT, first recommended by WHO study group on chemotherapy of leprosy for control programmes 2024, rapidly
treatment of 6 months for PB leprosy and of. 12 months for MB leprosy. Treatment of drug resistant leprosy. Two of the following second-line drugs
WHO recommended multidrug therapy (MDT) regimens. The Guidelines for the diagnosis, treatment and prevention of leprosy (WHO, 2024), recommends the same 3-drug regimen with rifampicin, dapsone and clofazimine for all leprosy patients, with a duration of treatment of 6 months for PB leprosy and of 12 months for MB leprosy.
Diagnosis, Treatment and Prevention of Leprosy The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target
Treatment of paucibacillary leprosy is with the medications dapsone, rifampicin, and clofazimine for six months. Treatment for multibacillary leprosy uses the
Treatment of Leprosy Neuritis. Microscopic presence of M. leprae within nerves has been demonstrated in all types of leprosy. So, the management of leprosy neuritis are treatment of leprosy with MDT, treatment of type 1 and type 2 reactions, anti-inflammatory treatment, reconstructive surgeries, physiotherapy, and rest.
WHO recommended multidrug therapy (MDT) regimens. The Guidelines for the diagnosis, treatment and prevention of leprosy (WHO, 2024), recommends the same 3-drug regimen with rifampicin, dapsone and clofazimine for all leprosy patients, with a duration of treatment of 6 months for PB leprosy and of 12 months for MB leprosy.
(not many others but enough).